跳至主要内容
临床试验/CTRI/2022/01/039825
CTRI/2022/01/039825尚未招募未知

Comparative study of oral Methotrexate vs oral Methotrexate along with Apremilast in patients with Moderate to Severe Chronic Plaque Psoriasis - CSOM-MAiP

GMERS Medical College and CIvil Hospital Sola0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients ready to be part of study and sign ICF.
  • 2. Patient presenting with Moderate to Severe Chronic Plaque Psoriasis according to the Rule of Tens (PASI score >10)

排除标准

  • 1. Patients who failed to give written consent.
  • 2. In patients in which Methotrexate and/or Apremilast is contraindicated
  • 3. Pregnant women and Lactating Mothers
  • 4. Patients with mild disease (PASI <10)
  • 5. Erythrodermic or pustular psoriasis, predominant scalp or nail involvement
  • 6. Patients who have taken methotrexate continuously or intermittently in more than 2.5gm total dose.
  • 7. Patients with hepatic or renal impairment, cardiac dysfunction, blood dyscrasias or any other systemic comorbidity.

研究者

发起方
GMERS Medical College and CIvil Hospital Sola

相似试验